US Patent Issued to Icahn School of Medicine at Mount Sinai, The United States Government as Represented by the Department of Veterans Affairs on July 7 for "Oxadiazolyl dihydropyrano[2,3-bpyridine inhibitors of HIPK2 for treating kidney fibrosis" (New York, California Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,956, issued on July 7, was assigned to Icahn School of Medicine at Mount Sinai (New York) and The United States Government as Represented by ... Read More

US Patent Issued to LAPKO on July 7 for "Inhibition of glial cell activation" (California Inventor)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,957, issued on July 7, was assigned to LAPKO INC (Las Vegas). "Inhibition of glial cell activation" was invented by Bruce Kovacs (Long Beach... Read More

US Patent Issued to Idemitsu Kosan on July 7 for "Polycyclic compound, and an organic electroluminescence device comprising the polycyclic compound" (Swiss, French Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,958, issued on July 7, was assigned to Idemitsu Kosan Co. Ltd. (Chiyoda-ku, Japan). "Polycyclic compound, and an organic electroluminescence... Read More

US Patent Issued to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on July 7 for "Polysubstituted imidazolo[4,5-c[1,2thiazine derivative and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,959, issued on July 7, was assigned to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea). "Polysub... Read More

US Patent Issued to MBQ Pharma on July 7 for "Heterocyclic inhibitors of Rho GTPases for the treatment of disease" (Florida, Puerto Rico Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,960, issued on July 7, was assigned to MBQ Pharma (Canovanas, Puerto Rico). "Heterocyclic inhibitors of Rho GTPases for the treatment of dis... Read More

US Patent Issued to Agios Pharmaceuticals on July 7 for "Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,961, issued on July 7, was assigned to Agios Pharmaceuticals Inc. (Cambridge, Mass.). "Compounds and methods useful for stabilizing phenylal... Read More

US Patent Issued to GENEVANT SCIENCES on July 7 for "Cationic lipids for lipid nanoparticle delivery of therapeutics to hepatic stellate cells" (Canadian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,963, issued on July 7, was assigned to GENEVANT SCIENCES GMBH (Basel, Switzerland). "Cationic lipids for lipid nanoparticle delivery of ther... Read More

US Patent Issued to GANNEX PHARMA on July 7 for "Crystal of thyroid hormone B receptor agonist, process for preparing the same and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,964, issued on July 7, was assigned to GANNEX PHARMA Co. LTD. (Shanghai). "Crystal of thyroid hormone B receptor agonist, process for prepar... Read More

US Patent Issued to TANAKA PRECIOUS METAL TECHNOLOGIES on July 7 for "Raw material for chemical deposition containing organoruthenium compound, and chemical deposition method using the raw material for chemical deposition" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,965, issued on July 7, was assigned to TANAKA PRECIOUS METAL TECHNOLOGIES Co. Ltd. (Tokyo). "Raw material for chemical deposition containing... Read More

US Patent Issued to Samsung Display on July 7 for "Organometallic compound and organic light-emitting device including the same" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,966, issued on July 7, was assigned to Samsung Display Co. Ltd. (Yongin-si, South Korea). "Organometallic compound and organic light-emittin... Read More

• ««
• «
• 126110
• 126111
• 126112
• 126113
• 126114
• 126115
• 126116
• 126117
• 126118
• 126119
• »
• »»